Boxer Capital, LLC Blueprint Medicines Corp Transaction History

Boxer Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $11.6 Million - $18.1 Million	-232,374 Reduced 45.8%	275,000 $18.1 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $7.76 Million - $9.55 Million	82,374 Added 19.38%	507,374 $54.3 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $34.4 Million - $46.5 Million	425,000 New	425,000 $43.7 Million
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $15.2 Million - $25.3 Million	-250,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $10.6 Million - $17.4 Million	250,000	250,000 $17.4 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.